Jinping Wan
24Patents
6h-index
69Co-inventors
68Inventor score
Filing activity: May 30, 2007 → Jul 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7824601B1 | Process of making a tubular implantable medical device | Textiles; Paper | 36 | Active |
| US8697058B2 | Cytocompatible alginate gels | Human Necessities | 14 | Active |
| US8388948B2 | Cytocompatible alginate gels | Human Necessities | 14 | Active |
| US8293226B1 | Cytocompatible alginate gels | Human Necessities | 8 | Active |
| US8221744B2 | Cytocompatible alginate gels | Human Necessities | 7 | Active |
| US9504653B2 | Microsphere drug delivery system for sustained intraocular release | Human Necessities | 7 | Active |
| US8044021B2 | Sustained release of apo A-I mimetic peptides and methods of treatment | Human Necessities | 5 | Active |
| US8703180B1 | Multiple growth factor compositions, methods of fabrication, and methods of treatment | Human Necessities | 4 | Active |
| US9289413B2 | Prostamide-containing intraocular implant | Human Necessities | 4 | Active |
| US9889142B2 | Prostamide-containing intraocular implant | Human Necessities | 3 | Active |
| US8765162B2 | Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same | Human Necessities | 3 | Active |
| US9572795B2 | Drug delivery system and method of treatment of vascular diseases using photodynamic therapy | Human Necessities | 3 | Active |
| US9259398B1 | Bioactive agent-loaded targeting micelles | Human Necessities | 3 | Active |
| US8895056B2 | Regional delivery of therapeutic agents for the treatment of vascular diseases | Human Necessities | 2 | Active |
| US8802184B2 | Medical devices containing biobeneficial particles | Performing Operations; Transporting | 2 | Active |
| US9173890B2 | Sustained release of Apo A-I mimetic peptides and methods of treatment | Human Necessities | 1 | Active |
| US10765629B2 | Solid complex, preparations and uses thereof | Human Necessities | 1 | Active |
| US10668081B2 | Prostamide-containing intraocular implant | Human Necessities | 0 | Active |
| US7985728B1 | Sustained release of Apo A-I mimetic peptides and methods of treatment | Human Necessities | 0 | Active |
| US11813334B2 | Polyethylene glycol conjugate drug, and preparation method therefor and use thereof | Human Necessities | 0 | Active |
| US8916187B2 | Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same | Human Necessities | 0 | Active |
| US9119787B2 | Microparticles for the treatment of disease | Human Necessities | 0 | Active |
| US8735344B2 | Sustained release of APO A-I mimetic peptides and methods of treatment | Human Necessities | 0 | Active |
| US12004995B2 | Intraocular implant with high loading of a prostamide | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.